RWD to the Rescue: Solving R&D Challenges for Pharma Companies

Life Sciences, Pharmaceutical, Commercialization & HEOR,
  • Friday, October 25, 2024 | 11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central)
  • 60 min

Discover an insightful webinar that focuses on the transformative potential of real-world data (RWD) in clinical research and healthcare strategy.

This webinar will cover how RWD can enhance the design and execution of clinical trials, leading to more efficient and effective asset strategies. Attendees will learn how to utilize RWD to better understand patient cohorts, define meaningful endpoints, assess trial feasibility and explore disease characteristics.

The expert speakers will explore the integration of artificial intelligence (AI) and advanced disease modeling techniques to identify and support underdiagnosed patient populations. The attendees will walk away with a better understanding of the critical role of RWD in developing comprehensive evidence plans, including safety assessments and long-term follow-up.

This webinar is designed for healthcare professionals, researchers and industry stakeholders who are keen to leverage RWD for innovative and impactful clinical solutions.

Register for this webinar today to learn how RWD can enhance the design and execution of clinical trials.

Keywords:
Register

Speakers

Gaelan Ritter, Head of Innovation and Digital Health Analytics, Bristol Myers Squibb

As the Head of Innovation and Digital Health, Gaelan Ritter and his team are responsible for creating and developing innovations across BMS. He co-leads the BMS digital innovation pillar for global drug development, which is enabling a spectrum of digital solutions, including several types of digital trial capabilities.

Gaelan is an industry leader in the development and infusion of digital innovation solutions that enable optimization of pharma drug development. In his past roles, Gaelan has led and developed strategic partnerships with large academic medical centers and networks. He has also supported trial design and start-up for the BMS oncology and immunology programs.

This experience led him to develop industry-leading trial design software and processes that create digital protocols and feed downstream systems and processes. He is passionate about not only the ideation and creation but also the development and business change that creates lasting advancement in the industry. Gaelan holds an MBA from Temple University along with MS in Human Physiology and Biophysics from Georgetown.

Message Presenter

Akiko Shimamura, Senior Vice President, Trial Design and Optimization, TriNetX

Akiko Shimamura is an experienced leader in the life sciences industry, having held a range of senior roles. As Senior Vice President at TriNetX, she is responsible for developing products and managing teams focused on trial design and optimization.

Her wealth of experience and knowledge make her an invaluable asset to TriNetX. As the former Vice President of Medidata, she has overseen products across RWE, commercial analytics and tokenization. Akiko has a wealth of experience in consulting having previously worked at McKinsey & Company where she provided advice to companies on life sciences and analytics.

Message Presenter

Message Presenter

Have questions or would like more information? Use the form below to send a message.

Who Should Attend?

This webinar will appeal to professionals in the following fields or those having the following job titles: 

  • Director of Feasibility/Feasibility Strategists/Feasibility Lead
  • Director of Clinical Trial Design
  • Clinical trial optimization/Site identification
  • Clinical development/operations/trial diversity
  • Director of Diversity, Equity and Inclusion in Clinical Trials

What You Will Learn

Attendees will learn about:

  • Using RWD to power the design of asset strategies and trials
  • Leveraging RWD to gain insights into cohorts, endpoints, feasibility and disease characteristics
  • The benefits of AI and disease modeling for underdiagnosed patients
  • The role RWD plays in the evidence plan (e.g., safety and long-term follow-up)

Xtalks Partner

TriNetX

TriNetX is a global network of healthcare organizations and life sciences companies driving real-world research to accelerate the development of new therapies. Through its self-service, HIPAA, GDPR, and LGPD-compliant platform of federated EHR, datasets, and consulting partnerships, TriNetX puts the power of real-world data into the hands of its worldwide community to improve protocol design, streamline trial operations, refine safety signals, and enrich real-world evidence generation.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account